Healthcare · Vaccine antigens production
Mauritania does not produce vaccine antigens — in 2026, the figure was 0 million doses. The country is entirely dependent on international immunization programs such as GAVI and purchases vaccines abroad. The lack of domestic biopharmaceutical production is due to insufficient investment, technology, and expertise. Instead, Mauritania focuses on livestock and fisheries — the key sectors of its economy. In vaccine production, the country ranks 72nd out of 197 countries.
Data for 2026 · unit: million doses
Position
#72 / 197
Mauritania world ranking
Country position on the scale from last to first place for this indicator.
MR
#72
#197#1
Trend
Change over time
Change in indicator over the available period.
0
1950
0
1990
0
2000
0
2010
0
2020
0
2025
0
2026
Values — million doses
Comparison
Top countries by Vaccine antigens production
Where Mauritania stands in the world ranking.
1
CNChina
5 K
2
USUSA
500
3
BRBrazil
400
4
FRFrance
160
5
INIndia
100
5
RURussia
100
7
CACanada
60
8
AUAustralia
50
Full world rankingarrow_forward
People also search for
Other pages of the reference by this indicator.
Frequently asked questions
Vaccine antigens production in Mauritania — how much?
Based on 2026 data — 0 million doses. This is rank #72 out of 197 countries.
What is Mauritania's rank by Vaccine antigens production?
Mauritania ranks #72 out of 197 countries in the world ranking by «Vaccine antigens production».
How has Vaccine antigens production changed in Mauritania?
Over the available period the indicator changed from 0 to 0 million doses.